期刊文献+

青少年原发性干燥综合征23例临床分析 被引量:2

Clinical features of primary Sjogren's syndrome in younger patients
下载PDF
导出
摘要 目的探讨青少年(≤30岁)原发性干燥综合征(primary Sjogren Syndrome,pSS)的临床特点。方法回顾性分析2009年9月—2011年7月于南京鼓楼医院风湿免疫科住院的23例pSS患者的临床特点。结果 23例pSS患者中女性22例,男性1例,平均年龄(23±4)岁,平均病程(6±6)个月。首发症状为口干和/或眼干占30%;其余血液系统损害(7/16),发热(4/16),腮腺肿大(1/16),胸闷(1/16),皮疹(1/16),双下肢麻木(1/16),关节痛(1/16)。结论青少年pSS发病患者中,女性多见,2/3以非口干眼干为首发症状,系统损害发病率高,其中血液系统受累多见。 Objective To investigate the clinical features of primary Sjogren's syndrome(pSS) in younger patients(age≤30).Methods The clinical features and laboratory indices of 23 younger pSS patients were collected in The Drum Tower Hospital from September 2009 to July 2011.And the data were retrospectively analyzed.Results There were 22 females and one male.The mean age was(23±4) years old,and the average disease duration was(6±6) months.The percentage of dry mouth/eye as an onset symptom was 30%.Other involvements were hematological system(7/16),fever(4/16),swelling of parotid gland(1/16),dyspnea(1/16),erythra(1/16),numbness on both lower extremities(1/16) and arthralgia(1/16).Conclusion Younger pSS patients are almost famales,and 2/3 of the symptoms are dry mouth/eye as onset symptoms.The incidence of system involvement is high especially the hematological system.We should think over and think highly of the above symptoms in clinical work.
出处 《安徽医药》 CAS 2012年第8期1108-1109,共2页 Anhui Medical and Pharmaceutical Journal
关键词 干燥综合征 口干症 青少年 临床特点 primary Sjogren's Syndrome xerostoma the younger clinical feature
  • 相关文献

参考文献9

二级参考文献32

  • 1姚中强,龙丽,栗占国.不同年龄发病的原发性干燥综合征的免疫学异常及临床特点的比较[J].中华风湿病学杂志,2006,10(11):683-686. 被引量:13
  • 2Vitali C,Bombardieri S,Jonsson R,et al.Classification criteria for Sjdgren' syndrome:a revised version of the European criteria proposed by the American-European Consensus Group[J].Ann Rheum Dis,2002,61(6):554 -558.
  • 3Civilibai M,Canpolat N,Yurt A,et al.A child with primary Sjogren syndrome and a review of the literature[J].Clin Pediatr (Phila),2007,46(8):738 -742.
  • 4Haga HJ,Jonsson R.The influence of age on disease manifestations and serological characteristics in primary Sjogren's syndrome[J].Scand J Rheumatol,1999,28(4):227-232.
  • 5Coeb V,Salle V,Duhaut P,et al.Clinical significance of autoantibodies recognizing Sjogren's syndrome A (SSA),SSB,calpastatin and alpha-fodrin in primary Sjogren' s syndrome[J].Clin Exp Immunol,2007,148(2):281 -287.
  • 6He Jing,Chen Qiaolin,Li Jing,et al.Antibodies to α fodrin-derived peptide in Sjogren's syndrome[J].Ann Rheum Dis,2006,65(4):549-550.
  • 7Davidson BKS,Kelly CA,Griffiths ID.Primary Sj(o)gren's syndrome in the North East of England:a long-term follow-up study.Rheumatology,1999,38:245-253.
  • 8Ramos-Casals M,Solans R Rosas J,et al.Primary Sjogren's syndrome in Spain:clinical and immunologic expression in 1010 patients.Medicine(Baltimore),2008,87:210-219.
  • 9Theander E,Jacobsson LT.Relationship of Sjogren's syndrome to other connective tissue and autoimmune disorders.Rheum Dis Clin North Am,2008,34:935-947.
  • 10Menelaos NM,Chryssoula G,Elias Z,et al.Si(o)gren's syndrome associated with systemic lupus erythematosus:clinical and laboratory profiles and comparison with primary Sj(o)gren's syndrome.Arthritis Rheum,2004,50:882-891.

共引文献80

同被引文献25

  • 1Li Y,Zhang K,Chen H,et al.A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren's syndrome at 7q11.23[J].Nature genetics,2013,6(1);34-36.
  • 2Segal B M,Pogatchnik B,Holker E,et al.Primary Sjogren's syn-drome:cognitive symptoms,mood,and cognitive performance[J].Acta Neurologica Scandinavica,2012,125(4):272-278.
  • 3Hofauer B,Bas M,Manour N,et al.Liposomal local therapy as treatment for sicca symptoms in patients with primary Sjogren's syndrome[J],HNO,2013,61(11):921-927.
  • 4Ohno S,Yu H,Dickinson D,et al.Epigallocatechin-3-gallate mod-ulates antioxidant and DNA repair-related proteins in exocrine glands of a primary Sjogren's syndrome mouse model prior to dis-ease onset[J].Autoimmunity,2012,45(7):540-546.
  • 5Chai J,Logigian EL.Neurological manifestations of primary Sjogren's syndrome[J].Current opinion in neurology,2010,23?5):509-513.
  • 6Mavragani CP,Crow MK.Activation of the type I interferon pathway in primary Sjogren's syndrome[J].J Autoimmun,2010,35(3):225-231.
  • 7Nordmark G,Eloranta ML,Ronnblom L.Primary Sjogren's syn-drome and the type I interferon system[J].Curr Pharmac Biote,2012,13(10):2054-2062.
  • 8Landewe RB?Houbiers JG,Van den Bosch F,et al.Intranasal ad ministration of recombinant human cartilage glycoprotein-39 as a treatment for rheumatoid arthritis:a phase Ⅱ,multicentre,doub-le-blind,randomized,placebo-controlled,paraliel-group,dose-find-ing trial[J].Ann Rheum Dis,2010,69(9):1655-1659.
  • 9Nordmark G,Eloranta ML,Eriksson P,et al.Genetic variation in the NCR3 locus is associated with anti-SSA/SSB positive primary sjogren's syndrome in Scandinavian samples[J].Arthritis and Rheumatism,2012,64(2):228-230.
  • 10颜淑敏,张文,李梦涛,赵岩,曾小峰,张奉春,董怡.原发性干燥综合征573例临床分析[J].中华风湿病学杂志,2010,14(4):223-227. 被引量:62

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部